相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The ALKF1174L Mutation Potentiates the Oncogenic Activity of MYCN in Neuroblastoma
Teeara Berry et al.
CANCER CELL (2012)
High-Throughput Molecular and Histopathologic Profiling of Tumor Tissue in a Novel Transplantable Model of Murine Neuroblastoma: New Tools for Pediatric Drug Discovery
Jimmy K. Stauffer et al.
CANCER INVESTIGATION (2012)
Unlicensed NK cells target neuroblastoma following anti-GD2 antibody treatment
Nidale Tarek et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Clinical Significance of Tumor-Associated Inflammatory Cells in Metastatic Neuroblastoma
Shahab Asgharzadeh et al.
JOURNAL OF CLINICAL ONCOLOGY (2012)
Depletion of CD25+ T cells from hematopoietic stem cell grafts increases posttransplantation vaccine-induced immunity to neuroblastoma
Weiqing Jing et al.
BLOOD (2011)
PD-1/PD-L1 Interactions Contribute to Functional T-Cell Impairment in Patients Who Relapse with Cancer After Allogeneic Stem Cell Transplantation
Wieger J. Norde et al.
CANCER RESEARCH (2011)
Tumor-infiltrating myeloid cells induce tumor cell resistance to cytotoxic T cells in mice
Tangying Lu et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Preclinical Models for Neuroblastoma: Establishing a Baseline for Treatment
Tal Teitz et al.
PLOS ONE (2011)
miRNA Expression Profiling of the Murine TH-MYCN Neuroblastoma Model Reveals Similarities with Human Tumors and Identifies Novel Candidate MiRNAs
Marta Terrile et al.
PLOS ONE (2011)
Immunomodulation with dendritic cells and donor lymphocyte infusion converge to induce graft vs neuroblastoma reactions without GVHD after allogeneic bone marrow transplantation
S. Ash et al.
BRITISH JOURNAL OF CANCER (2010)
Genotypes of NK Cell KIR Receptors, Their Ligands, and Fcγ Receptors in the Response of Neuroblastoma Patients to Hu14.18-IL2 Immunotherapy
David C. Delgado et al.
CANCER RESEARCH (2010)
Antitumor Activity of Hu14.18-IL2 in Patients With Relapsed/Refractory Neuroblastoma: A Children's Oncology Group (COG) Phase II Study
Suzanne Shusterman et al.
JOURNAL OF CLINICAL ONCOLOGY (2010)
miR-380-5p represses p53 to control cellular survival and is associated with poor outcome in MYCN-amplified neuroblastoma
Alexander Swarbrick et al.
NATURE MEDICINE (2010)
Anti-GD2 Antibody with GM-CSF, Interleukin-2, and Isotretinoin for Neuroblastoma.
Alice L. Yu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
MYCN Promotes the Expansion of Phox2B-Positive Neuronal Progenitors to Drive Neuroblastoma Development
Goleeta Alam et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
Comprehensive characterization of neuroblastoma cell line subtypes reveals bilineage potential similar to neural crest stem cells
Sandra Acosta et al.
BMC DEVELOPMENTAL BIOLOGY (2009)
KIR and HLA Genotypes Are Associated with Disease Progression and Survival following Autologous Hematopoietic Stem Cell Transplantation for High-Risk Neuroblastoma
Jeffrey M. Venstrom et al.
CLINICAL CANCER RESEARCH (2009)
Long-Term Results for Children With High-Risk Neuroblastoma Treated on a Randomized Trial of Myeloablative Therapy Followed by 13-cis-Retinoic Acid: A Children's Oncology Group Study
Katherine K. Matthay et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
A Simple PCR Method for Rapid Genotype Analysis of the TH-MYCN Transgenic Mouse
Seiki Haraguchi et al.
PLOS ONE (2009)
Histological profile of tumours from MYCN transgenic mice
H. C. Moore et al.
JOURNAL OF CLINICAL PATHOLOGY (2008)
Subsets of myeloid-derived suppressor cells in tumor-bearing mice
Je-In Youn et al.
JOURNAL OF IMMUNOLOGY (2008)
A rationally designed tyrosine hydroxylase DNA vaccine induces specific antineuroblastoma immunity
Nicole Huebener et al.
MOLECULAR CANCER THERAPEUTICS (2008)
Activation of tissue transglutaminase transcription by histone deacetylase inhibition as a therapeutic approach for Myc oncogenesis
Tao Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Cell lines from MYCN transgenic murine turnours reflect the molecular and biological characteristics of human neuroblastorna
Andy J. Cheng et al.
EUROPEAN JOURNAL OF CANCER (2007)
CD25+ regulatory T cell inhibition enhances vaccine-induced immunity to neuroblastoma
Bryon D. Johnson et al.
JOURNAL OF IMMUNOTHERAPY (2007)
Cancer-germline gene expression in pediatric solid tumors using quantitative real-time PCR
Joannes F. M. Jacobs et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
Immunosurveillance and survivin-specific T-cell immunity in children with high-risk neuroblastoma
Christina M. Coughlin et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Tumor mRNA-transfected dendritic cells stimulate the generation of CTL that recognize neuroblastoma-associated antigens and kill tumor cells: Immunotherapeutic implications
Fabio Morandi et al.
NEOPLASIA (2006)
FCGR2A polymorphism is correlated with clinical outcome after immunotherapy of neuroblastoma with anti-GD2 antibody and granulocyte macrophage colony-stimulating factor
NKV Cheung et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Mechanisms of immune evasion of human neuroblastoma
L Raffaghello et al.
CANCER LETTERS (2005)
Multiple defects of the antigen-processing machinery components in human neuroblastoma: immunotherapeutic implications
L Raffaghello et al.
ONCOGENE (2005)
Expression of MHC class I, MHC class II, and cancer germline antigens in neuroblastoma
M Wölfl et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2005)
Downregulation and/or release of NKG2D ligands as immune evasion strategy of human neuroblastoma
L Raffaghello et al.
NEOPLASIA (2004)
Mechanisms of embryonal tumor initiation:: Distinct roles for MycN expression and MYCN amplification
LM Hansford et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Immune cell-mediated antitumor activities of GD2-targeted liposomal c-myb antisense oligonucleotides containing CpG motifs
C Brignole et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
Effects of MYCN antisense oligonucleotide administration on tumorigenesis in a murine model of neuroblastoma
CA Burkhart et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2003)
Expression of costimulatory molecules in human neuroblastoma. Evidence that CD40+neuroblastoma cells undergo apoptosis following interaction with CD40L
I Airoldi et al.
BRITISH JOURNAL OF CANCER (2003)
Dendritic cells for NK/LAK activation:: rationale for multicellular immunotherapy in neuroblastoma patients
D Valteau-Couanet et al.
BLOOD (2002)
Lack of HLA-class I antigens in human neuroblastoma cells: analysis of its relationship to TAP and tapasin expression
MV Corrias et al.
TISSUE ANTIGENS (2001)
分享论文
